Meet the 10 innovative startups in the second cohort of the Ready2Scale acceleration program

The program provides comprehensive support and resources, including equity-free grants up to €60,000, a six-month acceleration program with market discovery missions, networking events, specialized one-on-one expert advice, and access to up to 100 mentors.

InSimili (Italy) is developing a drug discovery platform designed to help pharmaceutical companies reduce the time and cost of drug development by simulating the patient’s environment in vitro.

AlongRoute (Greece) is developing AI-powered ocean forecasts to help maritime software providers optimize ship routing, reduce fuel consumption, and cut emissions with high-accuracy, data-driven insights.

VoiceMed (Luxembourg) is working on a vocal biomarkers platform that helps healthcare providers and insurers detect and monitor lung diseases early through AI-powered acoustic analysis.

BioMedical Lab (Italy) is developing PD-Watch, a wearable app that aids in early Parkinson’s diagnosis and continuous monitoring, helping doctors refine treatments and enhance patient quality of life.

Motion Informatics (Israel) has created Spatial StimelMD, a technology that enhances motor rehabilitation for patients in Europe by tailoring therapy to neural patterns and intent through spatial computing, AR, AI analytics, and EMG technology.

BioHalo (Denmark) is introducing bio-based materials that serve as safe, eco-friendly, and high-performance replacements for harmful PFAS.

Nitrogen Sensing Solution (Portugal), also known as NS2, is a deep-tech startup specializing in smart biosensors for water quality, revolutionizing nitrogen management in sustainable aquaculture and agriculture.

Ecorbio (Cyprus) develops cleantech solutions to produce truly sustainable, scalable, and cost-effective EU biochemicals that help decarbonize multi-billion-dollar industries.

Valvur (Estonia) is building an AI-powered security layer for parents, schools, and game developers to protect gamers from cyberbullying and online threats by leveraging technology, fostering trust, and sharing knowledge.

Beat Therapeutics(Portugal) is pioneering a novel therapy to treat aggressive cancers, addressing critical unmet needs for safer and more effective treatments that improve patient outcomes.

The second batch of startups officially kicked off their journey at the InvestEU Deeptech Summit in Paris on March 10-11. The event provided them with an opportunity to connect with the Paris deep-tech ecosystem, and three startups had the chance to pitch their innovations on stage to global investors. The startups also participated in three insightful workshops, and project partners outlined the acceleration journey, covering investment readiness, market discovery missions, and funding utilization.

Kristiina Libe, Ready2Scale Project Manager, shared her thoughts on the new cohort and the kickoff event: “It is always exciting to see the level of innovation that startups bring to the program. This year’s cohort is an outstanding group of companies tackling some of the world’s biggest challenges with deep-tech solutions. The kickoff event in Paris was an excellent starting point, allowing them to engage with investors and key stakeholders early on. We are confident that the program will help them refine their business strategies, access new markets, and secure funding for further growth.”

Ready2Scale is no longer accepting applications, but several free Startup Academy webinars are coming up, offering valuable insights for entrepreneurs looking to scale their businesses. Check out the upcoming webinars here: https://ready2scale.eu/for-startups/

The Ready2Scale project is a collaborative effort by Tehnopol, Civitta, Poznan Science and Technology Park, and the European Business Angels Network, working together to help deep and digital tech startups scale and thrive.